Tabla 3: Mapa de sensibilidad a aislamientos principales (gram-negativos). |
||||||||
|
Escherichia coli, % N = 59 |
Pseudomonas aeruginosa, % N = 40 |
Klebsiella pneumoniae, % N = 28 |
Stenotrophomonas maltophilia, % N = 13 |
Acinetobacter baumannii, % N = 10 |
Proteus mirabilis, % N = 7 |
Enterobacter cloacae, % N = 7 |
Serratia marcescens, % N = 6 |
Amikacina |
93 |
77 |
92 |
46 |
0 |
100 |
100 |
80 |
Aztreonam |
32 |
0 |
47 |
0 |
0 |
50 |
67 |
– |
Cefepima |
43 |
60 |
56 |
39 |
30 |
57 |
86 |
60 |
Ceftazidima |
61 |
47 |
63 |
40 |
20 |
33 |
75 |
50 |
Ceftriaxona |
43 |
0 |
54 |
0 |
13 |
57 |
71 |
60 |
Ertapenem |
95 |
0 |
96 |
100 |
– |
100 |
86 |
100 |
Meropenem |
96 |
45 |
96 |
15 |
– |
86 |
100 |
80 |
Piperacilina / tazobactam |
82 |
56 |
59 |
14 |
0 |
100 |
50 |
– |
Tobramicina |
43 |
71 |
63 |
57 |
33 |
100 |
100 |
100 |
Colistina |
100 |
100 |
100 |
83 |
100 |
0 |
100 |
0 |
Ciprofloxacino |
16 |
72 |
50 |
46 |
20 |
67 |
86 |
80 |
Fosfomicina |
86 |
75 |
64 |
50 |
22 |
50 |
50 |
100 |
Tigeciclina |
100 |
0 |
75 |
75 |
63 |
0 |
100 |
100 |
Ceftolozano / tazobactam |
89 |
89 |
80 |
75 |
25 |
– |
– |
100 |
Ceftazidima / avibactam |
94 |
90 |
86 |
71 |
22 |
100 |
100 |
100 |